Depletion of HDAC7 and De-Repression of Nur77: a Mechanism for Sensitivity of Cutaneous Lymphoma (CTCL) Cells to Pan- Histone Deacetylase Inhibitor Panobinostat (LBH589)

K. Natarajan,J. Chen,R. Kolhe,K. Eaton,W. Fiskus,R. Rao,Y. Wang,P. Lee,P. Atadja,K. N. Bhalla

DOI: https://doi.org/10.1200/jco.2008.26.15_suppl.14542

IF: 45.3

2008-01-01

Journal of Clinical Oncology

Abstract:14542 Background: HDAC7 belongs to the class IIA histone deacetylases (HDACs) and is overexpressed in thymocytes, where it transcriptionally represses the proapoptotic nuclear orphan receptor Nur77. Following an apoptotic stimulus, Nur77 translocates from the nucleus to mitochondria, where it binds and converts Bcl-2 into a pro-apoptotic protein, allowing caspase activation and apoptosis. Panobinostat (P) (Novartis Pharmaceuticals) has a high level of clinical activity against advanced CTCL cells. However, the molecular basis of this activity remains unclear. Methods: RT-PCR, confocal immunofluorescent microscopy and immunoblot analyses were utilized to determine the effects of P on the levels and localization of HDAC7 and Nur77 in cultured CTCL HH and HUT78 cells. Apoptosis was determined by the morphologic features and by estimating the sub-G1 hypodiploid DNA-containing fraction of cells. The sensitizing effects of the ectopic overexpression of Nur77 and its knockdown by Nur77 siRNA on P-induced apoptosis were also determined. Results: Treatment with P (5 to 20 nM) rapidly (4 hours) depleted the in vitro and intracellular activity, as well as depleted the mRNA and protein levels of HDAC7, but simultaneously induced the mRNA and protein expression of Nur77 in human CTCL HH and HUT-78 cells. P induced Nur77 translocation from the nucleus to mitochondria. This was associated with apoptosis of HH and HUT-78 cells. Ectopic overexpression of Nur77 induced apoptosis and sensitized HH cells to P. Conversely, knockdown of Nur77 levels inhibited P-induced apoptosis of HH cells. Co-treatment with ABT-737, a Bcl-2/BclxL antagonist (0,1 to 1.0 uM) significantly increased P-induced apoptosis of CTCL cells. In 5 samples of primary CTCL cells, ex-vivo treatment with P also dose-dependently increased the % of non-viable cells to up to 35 to 82%. Conclusions: These findings mechanistically implicate the role of HDAC7 down regulation and resulting de-repression and mitochondrial translocation of Nur77 in sensitizing human CTCL cells to P-induced cell death. These results also indicate that co-treatment with an anti-Bcl-2 agent e.g., a BH3 domain-only mimetic, would augment the anti-CTCL activity of P. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Expert Testimony Other Remuneration Novartis Institute for Biomedical Research Inc. Novartis Institute for Biomedical Research Inc. Merck & Co., Novartis, Novartis Institute for Biomedical Research Inc.